BACKGROUND: Anecdotally, increasing number of @entity1 are seen at Korle Bu Teaching Hospital (KBTH) with @entity1313 . Neuro-ophthalmic symptoms and signs may help in timely diagnosis and intervention. OBJECTIVE: To evaluate the neuro-ophthalmic and clinical characteristics of @entity1313 in @entity1 presenting at a tertiary hospital in Ghana. STUDY DESIGN: A prospective case series involving 36 consecutive @entity1 newly diagnosed with @entity1313 from November 2010 to October 2011, at the Ophthalmology, Neurosurgery and Endocrine units of KBTH, Ghana. All @entity1 had clinical diagnosis of @entity1313 with confirmation by computerized tomography (CT) or magnetic resonance imaging (MRI). Thirteen @entity1 had histological confirmation of diagnosis. OUTCOME MEASURES: Presenting Visual acuity, Colour vision, @entity227 . RESULTS: Data of 36 @entity1 were analyzed. Ages ranged from 3 to 69years, mean (SD) 42.56(  16.6 years). Twenty-six (72%) were females. Tumours included @entity977 (20,55.5%), @entity1653 (10,27.8%), @entity5 (1,2.8%), @entity2946 (1,2.8%), @entity976 (1,2.8%), haemangioblastoma(1,2.8%), @entity5 (1,2.8%) and haemangioma(1,2.8%). Histologically confirmed @entity5 included @entity977 (9, 69.2%), @entity1653 (3, 23.1%), @entity976 (1, 7.7%). One @entity1 had both a @entity977 and @entity1653 . Blurred vision (30, 83.3%), @entity10 (28, 77.8%) and @entity3917 (13, 36.1%) were predominant symptoms. Commonest neuro-ophthalmic signs were @entity227 (62 eyes, 88.6%), @entity1952 (26, 74.3%), unilateral or bitemporal @entity1805 (15, 41.5%) and @entity2300 (12, 34.3%). Seven (19.4%) @entity1 were @entity227 and nine (25%) blind. Thirty-three of 72(45.8%) eyes had @entity1939 . CONCLUSIONS: Common neuro-ophthalmic characteristics were @entity227 , @entity10 , @entity227 , @entity1952 , and @entity2300 ( @entity2300 ). Significant numbers of @entity1 were @entity227 at presentation.

Neuro-Ophthalmic and Clinical Characteristics of XXXX in a Tertiary Hospital in Ghana.

@entity1 :: ('9606', 'Species') :: ['patient', 'patients'] @entity227 :: ('MESH:D014786', 'Disease') :: ['impaired colour vision', 'blind or visually impaired', 'visually impaired', 'Visual fields and Cranial nerve deficits', 'blurred vision'] @entity1952 :: ('MESH:D009896', 'Disease') :: ['optic atrophy'] @entity1313 :: ('MESH:D001932', 'Disease') :: ['brain tumour'] @entity5 :: ('MESH:D009369', 'Disease') :: ['choroid plexus tumour', 'tumours', 'thalamic tumour'] @entity2300 :: ('MESH:D011681', 'Disease') :: ['relative afferent pupillary defect', 'RAPD'] @entity1939 :: ('MESH:D001766', 'Disease') :: ['monocular blindness'] @entity1653 :: ('MESH:D008579', 'Disease') :: ['meningioma'] @entity1805 :: ('MESH:D006423', 'Disease') :: ['hemianopia'] @entity977 :: ('MESH:D010911', 'Disease') :: ['pituitary adenoma'] @entity976 :: ('MESH:D003397', 'Disease') :: ['craniopharyngioma'] @entity10 :: ('MESH:D006261', 'Disease') :: ['headache'] @entity3917 :: ('MESH:D020795', 'Disease') :: ['photophobia'] @entity2946 :: ('MESH:D008527', 'Disease') :: ['medulloblastoma']
@entity1313 :: (MESH:D001932,Disease) :: ['Brain Tumours']
